The Islet Product, Planning for Trials, and Manufacturing
S7
.1 Recapitulating the vascular niche to improve beta cell replacement therapies for T1DS7
.2 Stem cell-derived islets for treating diabetes: The Seraxis approachS7
.3 Planning for clinical trials: Lessons learned from autologous iPSC-derived productsS7
.4 Scale - up manufacturing; how to do it or not so easy?S7
.5 Panel Discussion and Q&A